TY - JOUR
T1 - Neuropathology of murine Sanfilippo D syndrome
AU - Takahashi, Keigo
AU - Le, Steven Q.
AU - Kan, Shih hsin
AU - Jansen, Matthew J.
AU - Dickson, Patricia I.
AU - Cooper, Jonathan D.
N1 - Funding Information:
This study was supported by grants from the National Institutes of Health 1R41NS089061, 2R42NS089061, and 2R44NS089061 to Phoenix Nest, and 1R01NS088766 to P.I.D. The MPS IIID mouse model was developed by Taconic as a generous prize to Jonah's Just Begun as part of the Rare Disease Science Challenge 2012, hosted by Assay Depot and the Rare Genomics Institute.Dr. Dickson receives research support from Genzyme and M6P Therapeutics.
Funding Information:
This study was supported by grants from the National Institutes of Health 1R41NS089061 , 2R42NS089061 , and 2R44NS089061 to Phoenix Nest, and 1R01NS088766 to P.I.D. The MPS IIID mouse model was developed by Taconic as a generous prize to Jonah's Just Begun as part of the Rare Disease Science Challenge 2012, hosted by Assay Depot and the Rare Genomics Institute.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/12
Y1 - 2021/12
N2 - Sanfilippo D syndrome (mucopolysaccharidosis type IIID) is a lysosomal storage disorder caused by the deficiency of N-acetylglucosamine-6-sulfatase (GNS). A mouse model was generated by constitutive knockout of the Gns gene. We studied affected mice and controls at 12, 24, 36, and 48 weeks of age for neuropathological markers of disease in the somatosensory cortex, primary motor cortex, ventral posterior nuclei of the thalamus, striatum, hippocampus, and lateral and medial entorhinal cortex. We found significantly increased immunostaining for glial fibrillary associated protein (GFAP), CD68 (a marker of activated microglia), and lysosomal-associated membrane protein-1 (LAMP-1) in Sanfilippo D mice compared to controls at 12 weeks of age in all brain regions. Intergroup differences were marked for GFAP and CD68 staining, with levels in Sanfilippo D mice consistently above controls at all age groups. Intergroup differences in LAMP-1 staining were more pronounced in 12- and 24-week age groups compared to 36- and 48-week groups, as control animals showed some LAMP-1 staining at later timepoints in some brain regions. We also evaluated the somatosensory cortex, medial entorhinal cortex, reticular nucleus of the thalamus, medial amygdala, and hippocampal hilus for subunit c of mitochondrial ATP synthase (SCMAS). We found a progressive accumulation of SCMAS in most brain regions of Sanfilippo D mice compared to controls by 24 weeks of age. Cataloging the regional neuropathology of Sanfilippo D mice may aid in understanding the disease pathogenesis and designing preclinical studies to test brain-directed treatments.
AB - Sanfilippo D syndrome (mucopolysaccharidosis type IIID) is a lysosomal storage disorder caused by the deficiency of N-acetylglucosamine-6-sulfatase (GNS). A mouse model was generated by constitutive knockout of the Gns gene. We studied affected mice and controls at 12, 24, 36, and 48 weeks of age for neuropathological markers of disease in the somatosensory cortex, primary motor cortex, ventral posterior nuclei of the thalamus, striatum, hippocampus, and lateral and medial entorhinal cortex. We found significantly increased immunostaining for glial fibrillary associated protein (GFAP), CD68 (a marker of activated microglia), and lysosomal-associated membrane protein-1 (LAMP-1) in Sanfilippo D mice compared to controls at 12 weeks of age in all brain regions. Intergroup differences were marked for GFAP and CD68 staining, with levels in Sanfilippo D mice consistently above controls at all age groups. Intergroup differences in LAMP-1 staining were more pronounced in 12- and 24-week age groups compared to 36- and 48-week groups, as control animals showed some LAMP-1 staining at later timepoints in some brain regions. We also evaluated the somatosensory cortex, medial entorhinal cortex, reticular nucleus of the thalamus, medial amygdala, and hippocampal hilus for subunit c of mitochondrial ATP synthase (SCMAS). We found a progressive accumulation of SCMAS in most brain regions of Sanfilippo D mice compared to controls by 24 weeks of age. Cataloging the regional neuropathology of Sanfilippo D mice may aid in understanding the disease pathogenesis and designing preclinical studies to test brain-directed treatments.
KW - Glycosaminoglycan
KW - Lysosomal storage disease
KW - Mucopolysaccharidosis
UR - http://www.scopus.com/inward/record.url?scp=85120677525&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2021.11.010
DO - 10.1016/j.ymgme.2021.11.010
M3 - Article
C2 - 34844863
AN - SCOPUS:85120677525
SN - 1096-7192
VL - 134
SP - 323
EP - 329
JO - Molecular Genetics and Metabolism
JF - Molecular Genetics and Metabolism
IS - 4
ER -